Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rapid Therapeutic Science Laboratories, Inc. (RTSL) Other financing activities (2019 - 2022)

Rapid Therapeutic Science Laboratories' Other financing activities history spans 4 years, with the latest figure at -$118420.0 for Q4 2022.

  • For Q4 2022, Other financing activities changed N/A year-over-year to -$118420.0; the TTM value through Dec 2022 reached $20000.0, changed N/A, while the annual FY2022 figure was $20000.0, 0.0% changed from the prior year.
  • Other financing activities for Q4 2022 was -$118420.0 at Rapid Therapeutic Science Laboratories, down from $59210.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $339584.0 in Q2 2020 and bottomed at -$118420.0 in Q4 2022.
  • The 4-year median for Other financing activities is $20000.0 (2021), against an average of $50233.4.
  • The largest YoY upside for Other financing activities was 3058.92% in 2020 against a maximum downside of 88.37% in 2020.
  • A 4-year view of Other financing activities shows it stood at $10750.0 in 2019, then tumbled by 88.37% to $1250.0 in 2020, then soared by 1500.0% to $20000.0 in 2021, then crashed by 692.1% to -$118420.0 in 2022.
  • Per Business Quant, the three most recent readings for RTSL's Other financing activities are -$118420.0 (Q4 2022), $59210.0 (Q3 2022), and $59210.0 (Q2 2022).